Geron
GERN
#7198
Rank
NZ$1.07 B
Marketcap
NZ$1.67
Share price
-7.50%
Change (1 day)
-14.99%
Change (1 year)

EPS for Geron (GERN)

EPS in 2026 (TTM): NZ-$0.14

According to Geron's latest financial reports the company's current EPS (TTM) is NZ-$0.15. In 2025 the company made an earnings per share (EPS) of NZ-$0.24 an increase over its 2024 EPS that were of NZ-$0.49.

EPS history for Geron from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$0.14-41.24%
2025NZ-$0.24-51.85%
2024NZ-$0.49-18.18%
2023NZ-$0.60-8.33%
2022NZ-$0.65-0%
2021NZ-$0.6533.33%
2020NZ-$0.49-25%
2019NZ-$0.65140%
2018NZ-$0.27-16.67%
2017NZ-$0.33-0%
2016NZ-$0.33-1.2970366926827E+18%
2015NZ$0.0000000000-100%
2014NZ-$0.44
2012NZ-$0.98

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Gilead Sciences
GILD
NZ-$5.64 3,775.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
NZ$3.82-2,725.00%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
NZ-$1.06 625.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
NZ$2.13-1,562.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
NZ-$53.28 36,512.50%๐Ÿ‡บ๐Ÿ‡ธ USA